Evrofarma SA (ATH:EVROF)
3.120
+0.020 (0.65%)
At close: Dec 5, 2025
Evrofarma Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.32 | 0.66 | 1.44 | 0.25 | 3.11 | Upgrade
|
| Cash & Short-Term Investments | 3.32 | 0.66 | 1.44 | 0.25 | 3.11 | Upgrade
|
| Cash Growth | 405.94% | -54.28% | 477.11% | -91.99% | 2832.07% | Upgrade
|
| Receivables | 7.37 | 9.17 | 11.72 | 13.69 | 12.15 | Upgrade
|
| Inventory | 7.11 | 6.52 | 5.56 | 3.07 | 3.57 | Upgrade
|
| Other Current Assets | - | -0 | - | - | - | Upgrade
|
| Total Current Assets | 17.8 | 16.34 | 18.71 | 17.01 | 18.83 | Upgrade
|
| Property, Plant & Equipment | 24.66 | 25.57 | 24.95 | 24.41 | 22.46 | Upgrade
|
| Long-Term Investments | 0.22 | 0.01 | 0.06 | 0.04 | 0.04 | Upgrade
|
| Other Intangible Assets | 0.13 | 0.05 | 0.06 | 0.1 | 0.13 | Upgrade
|
| Long-Term Accounts Receivable | 0.03 | 0.33 | 0.03 | 0.03 | 0.02 | Upgrade
|
| Other Long-Term Assets | 5.4 | 5.06 | 5.01 | 4.94 | 4.9 | Upgrade
|
| Total Assets | 48.24 | 47.36 | 48.81 | 46.52 | 46.38 | Upgrade
|
| Accounts Payable | 6.12 | 2.39 | 4.45 | 3.44 | 2.94 | Upgrade
|
| Accrued Expenses | - | 0.5 | 0.45 | 0.87 | 0.32 | Upgrade
|
| Short-Term Debt | 11.59 | 3.9 | 2.44 | 0.72 | 1.92 | Upgrade
|
| Current Portion of Long-Term Debt | - | 3.08 | 2.71 | 2.5 | 2.63 | Upgrade
|
| Current Portion of Leases | 0.07 | 0.04 | 0.04 | 0.03 | 0.02 | Upgrade
|
| Current Income Taxes Payable | 0.49 | 0.4 | 0.11 | - | 0.02 | Upgrade
|
| Other Current Liabilities | - | 2.73 | 2.48 | 2.64 | 2.85 | Upgrade
|
| Total Current Liabilities | 18.26 | 13.04 | 12.67 | 10.2 | 10.71 | Upgrade
|
| Long-Term Debt | 5.16 | 12.45 | 16.13 | 18.05 | 16.63 | Upgrade
|
| Long-Term Leases | 0.14 | 0.07 | 0.06 | 0.01 | 0.01 | Upgrade
|
| Long-Term Unearned Revenue | 5.73 | 4.43 | 4.69 | 4.42 | 4.82 | Upgrade
|
| Pension & Post-Retirement Benefits | 0.08 | 0.07 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.04 | 1.08 | 1.18 | 1.18 | 1.19 | Upgrade
|
| Other Long-Term Liabilities | -0 | - | -0 | - | - | Upgrade
|
| Total Liabilities | 30.41 | 31.13 | 34.79 | 33.92 | 33.42 | Upgrade
|
| Common Stock | 5.74 | 5.74 | 12.03 | 12.03 | 12.03 | Upgrade
|
| Additional Paid-In Capital | - | - | 0.94 | 0.94 | 0.94 | Upgrade
|
| Retained Earnings | 8.46 | 7.42 | -1.49 | -0.38 | -0.01 | Upgrade
|
| Comprehensive Income & Other | 3.62 | 3.06 | 2.55 | 0.02 | - | Upgrade
|
| Shareholders' Equity | 17.83 | 16.23 | 14.03 | 12.61 | 12.96 | Upgrade
|
| Total Liabilities & Equity | 48.24 | 47.36 | 48.81 | 46.52 | 46.38 | Upgrade
|
| Total Debt | 16.95 | 19.53 | 21.38 | 21.31 | 21.22 | Upgrade
|
| Net Cash (Debt) | -13.63 | -18.87 | -19.94 | -21.06 | -18.11 | Upgrade
|
| Net Cash Per Share | - | -1.38 | -1.46 | -1.54 | -1.32 | Upgrade
|
| Filing Date Shares Outstanding | - | 13.67 | 13.67 | 13.67 | 13.67 | Upgrade
|
| Total Common Shares Outstanding | - | 13.67 | 13.67 | 13.67 | 13.67 | Upgrade
|
| Working Capital | -0.46 | 3.3 | 6.04 | 6.81 | 8.12 | Upgrade
|
| Book Value Per Share | - | 1.19 | 1.03 | 0.92 | 0.95 | Upgrade
|
| Tangible Book Value | 17.69 | 16.18 | 13.97 | 12.51 | 12.83 | Upgrade
|
| Tangible Book Value Per Share | - | 1.18 | 1.02 | 0.91 | 0.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.